Search





Search





Tarsus Pharmaceuticals Inc

TARS

Add to Watchlist

64.790USD

-0.540-0.83%

Close 08-07 16:00（ET）Quotes delayed by 15 min

2.79BMarket Cap

LossP/E TTM

Tarsus Pharmaceuticals Inc

64.790

-0.540-0.83%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Revenue Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Revenue Earnings Company Valuation Risk Assessment

TARS Cash Flow Statement

You can access the annual and quarterly cash flow statements of Tarsus Pharmaceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

308.33%61.22M

-19.37%-24.65M

187.14%19.33M

311.01%18.26M

-104.02%-29.39M

45.35%-20.65M

43.61%-22.18M

73.26%-8.65M

39.55%-14.40M

-72.00%-37.79M

-261.73%-39.34M

-73.89%-32.36M

-459.43%-23.83M

-43.73%-21.97M

10.29%-10.87M

-361.68%-18.61M

-120.72%-4.26M

-29.61%-15.29M

-21.05%-12.12M

208.22%7.11M

--20.55M

---11.79M

---10.01M

---6.57M

Net income from continuing operations

8.80%-18.55M

72.27%-6.97M

63.77%-8.37M

46.26%-12.59M

38.90%-20.34M

29.70%-25.12M

44.84%-23.11M

40.18%-23.42M

-5.94%-33.29M

-52.57%-35.73M

-208.13%-41.90M

-73.91%-39.15M

-447.17%-31.42M

-15.72%-23.42M

8.43%-13.60M

-43.41%-22.51M

-190.51%-5.74M

-295.05%-20.24M

-29.51%-14.85M

-54.85%-15.70M

--6.34M

--10.38M

---11.47M

---10.14M

Operating gains losses

120.75%1.00M

-5.00%437.00K

2.55%443.00K

61.97%460.00K

89.54%453.00K

70.37%460.00K

24.50%432.00K

16.39%284.00K

31.32%239.00K

159.62%270.00K

254.08%347.00K

159.57%244.00K

97.83%182.00K

153.66%104.00K

145.00%98.00K

13.25%94.00K

-26.40%92.00K

-35.94%41.00K

-27.27%40.00K

245.83%83.00K

--125.00K

--64.00K

--55.00K

--24.00K

Other non-cash items

793.61%9.56M

39.37%-613.00K

46.56%-629.00K

-41.72%-1.19M

-251.76%-1.38M

-2197.73%-1.01M

-1105.98%-1.18M

-222.69%-839.00K

205.83%908.00K

96.44%-44.00K

111.12%117.00K

-275.68%-260.00K

-544.56%-858.00K

-831.36%-1.24M

-991.53%-1.05M

55.79%148.00K

171.83%193.00K

-96.93%169.00K

110.71%118.00K

-97.00%95.00K

--71.00K

--5.50M

--56.00K

--3.17M

Change in working capital

423.64%52.93M

-1443.25%-29.48M

337.04%13.57M

144.41%19.33M

-259.53%-16.36M

77.76%-1.91M

-104.03%-5.73M

462.85%7.91M

229.12%10.25M

-510.45%-8.59M

-3402.35%-2.81M

3093.18%1.41M

214.90%3.12M

-186.27%-1.41M

129.73%85.00K

-99.78%44.00K

-126.22%-2.71M

105.59%1.63M

-95.91%37.00K

13712.33%20.17M

--10.34M

---29.17M

--905.00K

--146.00K

-Change in receivables

383.49%18.92M

-87.00%-30.10M

28.06%-12.77M

-2729.85%-14.10M

651.06%3.91M

-17.94%-16.09M

-56.53%-17.75M

108.75%536.00K

-80.49%521.00K

-2152.18%-13.65M

-2744.06%-11.34M

-80.54%-6.12M

1037.19%2.67M

374.79%665.00K

832.61%429.00K

-116.94%-3.39M

-102.32%-285.00K

99.25%-242.00K

355.56%46.00K

--20.02M

--12.29M

---32.43M

---18.00K

--0.00

-Change in inventory

116.95%198.00K

-133.33%-196.00K

-336.12%-536.00K

105.67%37.00K

-68.79%-1.17M

90.96%-84.00K

107.34%227.00K

-4246.67%-652.00K

---692.00K

---929.00K

---3.09M

---15.00K

----

-Change in prepaid expenses

173.81%17.11M

-251.79%-13.24M

206.30%8.19M

794.34%7.98M

-3121.38%-23.17M

719.25%8.72M

-313.86%-7.70M

-44.89%-1.15M

255.89%767.00K

314.40%1.06M

-46.31%-1.86M

-198.51%-793.00K

58.31%-492.00K

-72.25%257.00K

7.83%-1.27M

-6.83%805.00K

2.16%-1.18M

388.47%926.00K

-684.75%-1.38M

173.59%864.00K

---1.21M

---321.00K

--236.00K

---1.17M

-Change in payables and accrued expense

----

-31.79%7.71M

-302.96%-30.54M

306.31%23.84M

-67.63%2.29M

-8.32%11.31M

86.62%15.05M

0.93%5.87M

1632.76%7.09M

1279.25%12.34M

2303.01%8.06M

339.79%5.81M

119.44%409.00K

-153.12%-1.05M

-202.52%-366.00K

220.29%1.32M

-377.10%-2.10M

-61.11%1.97M

66.05%357.00K

-202.52%-1.10M

---441.00K

--5.06M

--215.00K

--1.07M

-Change in other current assets

-46.08%55.00K

12.80%141.00K

-807.14%-381.00K

-1592.00%-373.00K

-78.88%102.00K

17.92%125.00K

61.82%-42.00K

124.51%25.00K

188.79%483.00K

178.95%106.00K

21.43%-110.00K

---102.00K

-511.24%-544.00K

171.43%38.00K

-128.17%-140.00K

100.00%0.00

91.69%-89.00K

101.12%14.00K

1135.42%497.00K

---436.00K

---1.07M

---1.25M

---48.00K

--0.00

-Change in other current liabilities

----

--0.00

100.00%0.00

-100.00%0.00

96.55%-1.00K

-2800.00%-232.00K

-93.07%189.00K

1200.00%33.00K

-3.57%-29.00K

81.40%-8.00K

58.33%2.73M

-106.98%-3.00K

-75.00%-28.00K

-134.96%-43.00K

231.35%1.72M

-82.66%43.00K

---16.00K

--123.00K

--520.00K

--248.00K

Cash from non-recurring investing activities

Cash from operating activities

308.33%61.22M

-19.37%-24.65M

187.14%19.33M

311.01%18.26M

-104.02%-29.39M

45.35%-20.65M

43.61%-22.18M

73.26%-8.65M

39.55%-14.40M

-72.00%-37.79M

-261.73%-39.34M

-73.89%-32.36M

-459.43%-23.83M

-43.73%-21.97M

10.29%-10.87M

-361.68%-18.61M

-120.72%-4.26M

-29.61%-15.29M

-21.05%-12.12M

208.22%7.11M

--20.55M

---11.79M

---10.01M

---6.57M

Investing cash flow

Net cash from continuing investing activities

306.49%4.07M

886.10%5.82M

25.35%6.36M

577.30%1.91M

-3.66%1.00M

239.08%590.00K

--5.07M

-93.55%282.00K

32.02%1.04M

-48.82%174.00K

-100.00%0.00

4457.29%4.38M

545.08%787.00K

111.18%340.00K

-53.65%127.00K

-20.66%96.00K

662.50%122.00K

-8.00%161.00K

648.00%274.00K

-10.37%121.00K

--16.00K

--175.00K

---50.00K

--135.00K

Capital expenditures

306.49%4.07M

886.10%5.82M

25.35%6.36M

577.30%1.91M

-3.66%1.00M

239.08%590.00K

--5.07M

-93.55%282.00K

32.02%1.04M

-48.82%174.00K

-100.00%0.00

4457.29%4.38M

545.08%787.00K

111.18%340.00K

-53.65%127.00K

-20.66%96.00K

662.50%122.00K

-8.00%161.00K

--274.00K

-10.37%121.00K

--16.00K

--175.00K

----

--135.00K

Net cash flow from disposal of fixed assets

306.49%4.07M

886.10%5.82M

8730.56%6.36M

577.30%1.91M

-3.66%1.00M

239.08%590.00K

--72.00K

-24.80%282.00K

32.02%1.04M

-48.82%174.00K

-100.00%0.00

290.63%375.00K

545.08%787.00K

111.18%340.00K

-53.65%127.00K

-20.66%96.00K

662.50%122.00K

-8.00%161.00K

648.00%274.00K

-10.37%121.00K

--16.00K

--175.00K

---50.00K

--135.00K

Net cash flow from intangible asset transactions

----

--5.00M

----

--0.00

--4.00M

----

Net cash flow from investment products

182.73%41.95M

-53.54%-52.74M

202.07%55.63M

-183.08%-2.83M

-28.41%-50.70M

66.34%-34.35M

-405.33%-54.50M

-93.41%3.41M

-160.86%-39.49M

-977.17%-102.05M

120.50%17.85M

190.73%51.74M

--64.88M

--11.63M

---87.09M

---57.03M

----

Net cash flow from other investing activities

--0.00

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

173.26%37.88M

-67.60%-58.56M

182.71%49.27M

-251.63%-4.74M

-27.59%-51.70M

65.82%-34.94M

-433.75%-59.57M

-93.40%3.13M

-163.23%-40.52M

-1005.12%-102.22M

120.47%17.85M

182.92%47.37M

52634.43%64.09M

7114.91%11.29M

-31731.75%-87.22M

-47112.40%-57.13M

-662.50%-122.00K

8.00%-161.00K

-648.00%-274.00K

10.37%-121.00K

---16.00K

---175.00K

--50.00K

---135.00K

Financing cash flow

Cash flow from continuous financing activities

69.16%3.30M

-99.12%1.20M

-21.01%2.31M

300.94%2.56M

-95.39%1.95M

25.55%136.56M

-85.19%2.93M

-99.39%639.00K

8197.84%42.32M

2069.78%108.77M

7384.85%19.76M

77227.21%104.89M

-99.32%510.00K

-73.79%5.01M

456.76%264.00K

-281.33%-136.00K

7473300.00%74.73M

100557.89%19.13M

-100.08%-74.00K

-99.81%75.00K

--1.00K

--19.00K

--91.76M

--39.90M

Net cash flow from debt Issuance/repayment

----

--0.00

-100.00%0.00

----

--0.00

-100.00%0.00

--75.00M

-100.00%0.00

--0.00

--5.00M

--0.00

-75.00%5.00M

--0.00

--20.00M

----

--0.00

Net cash flow from common stock issuance/repurchase

100.00%0.00

-100.00%0.00

--0.00

100.00%0.00

-29.20%-354.00K

37.04%135.13M

-100.00%0.00

-100.04%-43.00K

---274.00K

--98.60M

--19.22M

45685.78%99.38M

----

--0.00

---218.00K

--74.57M

----

Net cash flow from preferred stock issuance/repurchase

----

100.00%0.00

-100.00%0.00

--0.00

---244.00K

--40.00M

Proceeds from stock option exercised by employees

-19.17%1.86M

-16.21%1.20M

-21.01%2.31M

255.34%2.56M

-21.94%2.31M

79.18%1.44M

444.05%2.93M

39.73%721.00K

479.22%2.95M

6069.23%802.00K

103.79%538.00K

529.27%516.00K

113.39%510.00K

--13.00K

15.28%264.00K

9.33%82.00K

23800.00%239.00K

-100.00%0.00

5625.00%229.00K

-67.53%75.00K

--1.00K

--19.00K

--4.00K

--231.00K

Proceeds from issuance of warrants

----

--0.00

-100.00%0.00

--0.00

--9.37M

----

Net cash flow from other financing activities

--1.44M

--0.00

100.00%0.00

----

--0.00

---39.00K

---35.36M

----

--0.00

100.00%0.00

--0.00

---75.00K

---875.00K

-100.33%-303.00K

----

--92.00M

---330.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

69.16%3.30M

-99.12%1.20M

-21.01%2.31M

300.94%2.56M

-95.39%1.95M

25.55%136.56M

-85.19%2.93M

-99.39%639.00K

8197.84%42.32M

2069.78%108.77M

7384.85%19.76M

77227.21%104.89M

-99.32%510.00K

-73.79%5.01M

456.76%264.00K

-281.33%-136.00K

7473300.00%74.73M

100557.89%19.13M

-100.08%-74.00K

-99.81%75.00K

--1.00K

--19.00K

--91.76M

--39.90M

Net cash flow

Beginning cash balance

----

91.21%186.20M

-34.57%115.29M

-45.22%99.21M

-7.93%178.35M

-56.71%97.38M

-22.26%176.21M

69.61%181.09M

193.51%193.71M

213.91%224.95M

33.74%226.67M

-56.48%106.77M

-62.29%66.00M

-58.17%71.66M

-7.79%169.49M

38.83%245.36M

12.04%175.01M

1.89%171.33M

112.86%183.80M

232.49%176.74M

--156.20M

--168.15M

--86.35M

--53.16M

Current period cash flow changes

229.40%102.40M

-201.29%-82.01M

189.96%70.92M

429.09%16.08M

-527.59%-79.14M

359.17%80.97M

-4469.80%-78.83M

-104.07%-4.88M

-130.93%-12.61M

-451.69%-31.24M

98.24%-1.73M

258.02%119.90M

-42.04%40.78M

-253.97%-5.66M

-684.58%-97.83M

-1173.79%-75.87M

242.58%70.35M

130.78%3.68M

-115.24%-12.47M

-78.71%7.07M

--20.54M

---11.95M

--81.80M

--33.19M

Ending cash balance

108.24%206.60M

-41.58%104.19M

91.21%186.20M

-34.57%115.29M

-45.22%99.21M

-7.93%178.35M

-56.71%97.38M

-22.26%176.21M

69.61%181.09M

193.51%193.71M

213.91%224.95M

33.74%226.67M

-56.48%106.77M

-62.29%66.00M

-58.17%71.66M

-7.79%169.49M

38.83%245.36M

12.04%175.01M

1.89%171.33M

112.86%183.80M

--176.74M

--156.20M

--168.15M

--86.35M

Free cash flow

288.08%57.15M

-43.45%-30.47M

147.60%12.97M

282.98%16.35M

-96.78%-30.39M

44.05%-21.24M

30.71%-27.25M

75.68%-8.93M

37.26%-15.44M

-70.16%-37.96M

-257.56%-39.34M

-96.38%-36.74M

-461.81%-24.61M

-44.43%-22.31M

11.25%-11.00M

-367.59%-18.71M

-121.33%-4.38M

-29.06%-15.45M

-23.79%-12.39M

204.23%6.99M

--20.54M

---11.97M

---10.01M

---6.71M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Tarsus Pharmaceuticals Inc Generate?



Tarsus Pharmaceuticals Inc generated -12.45M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Tarsus Pharmaceuticals Inc's Operating Cash Flow Change Year Over Year?



Tarsus Pharmaceuticals Inc's operating cash flow increased by 85.00% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Tarsus Pharmaceuticals Inc Spend on Capital Expenditures?



Tarsus Pharmaceuticals Inc spent 9.86M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Tarsus Pharmaceuticals Inc's Financing Cash Flow Changed?



Tarsus Pharmaceuticals Inc used 143.39M in financing activities in the latest quarter.

What is free cash flow and why does it matter for TARS?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Tarsus Pharmaceuticals Inc’s free cash flow in the latest quarter?



Free cash flow was -22.31M reflecting a 75.10% change from the previous year.